Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marc G Ghany

Showing results (41-50 of 182) with videos related to

Pageof 19
Sort By:
JAMA|March 7, 2023
Moving the Needle to Reduce Acetaminophen (Paracetamol) HepatotoxicityMarc G Ghany, Paul B Watkins
Infectious Disease Clinics of North America|March 11, 2006
Assessment and management of chronic hepatitis BMarc G Ghany, Edward C Doo
Gastroenterology Clinics of North America|May 12, 2020
Hepatitis B: Current Status of Therapy and Future TherapiesElias Spyrou, Coleman I Smith, Marc G Ghany
Hepatology (Baltimore, Md.)|August 21, 2013
Reply: To PMID 23703931Mazen Noureddin, Elizabeth C Wright, Marc G Ghany
Gastroenterology|October 15, 2022
Current Best Practice in Hepatitis B Management and Understanding Long-term Prospects for CureDavid Yardeni, Kyong-Mi Chang, Marc G Ghany
Antiviral Chemistry & Chemotherapy|May 18, 2012
The application and mechanism of action of ribavirin in therapy of hepatitis CEmmanuel Thomas, Marc G Ghany, T Jake Liang
Journal of Hepatology|August 6, 2017
Hepatitis B cure: From discovery to regulatory approvalAnna S Lok, Fabien Zoulim, Geoffrey Dusheiko, et al.
Hepatology (Baltimore, Md.)|December 17, 2020
Liver Disease and Coronavirus Disease 2019: From Pathogenesis to Clinical CareAntonio Saviano, Florian Wrensch, Marc G Ghany, et al.
Journal of Hepatology|March 10, 2024
Reply to: "Ultrasensitive HBsAg testing predicts HBsAg seroreversion outcomes: Considerations for new and existing therapies"Marc G Ghany, Maria Buti, Pietro Lampertico, et al.
Journal of Hepatology|June 28, 2023
Guidance on treatment endpoints and study design for clinical trials aiming to achieve cure in chronic hepatitis B and D: Report from the 2022 AASLD-EASL HBV-HDV Treatment Endpoints ConferenceMarc G Ghany, Maria Buti, Pietro Lampertico, et al.
Pageof 19

Showing results (41-50 of 182) with videos related to

Sort By:
Pageof 19
JAMA|March 7, 2023
Moving the Needle to Reduce Acetaminophen (Paracetamol) HepatotoxicityMarc G Ghany, Paul B Watkins
Infectious Disease Clinics of North America|March 11, 2006
Assessment and management of chronic hepatitis BMarc G Ghany, Edward C Doo
Gastroenterology Clinics of North America|May 12, 2020
Hepatitis B: Current Status of Therapy and Future TherapiesElias Spyrou, Coleman I Smith, Marc G Ghany
Hepatology (Baltimore, Md.)|August 21, 2013
Reply: To PMID 23703931Mazen Noureddin, Elizabeth C Wright, Marc G Ghany
Gastroenterology|October 15, 2022
Current Best Practice in Hepatitis B Management and Understanding Long-term Prospects for CureDavid Yardeni, Kyong-Mi Chang, Marc G Ghany
Antiviral Chemistry & Chemotherapy|May 18, 2012
The application and mechanism of action of ribavirin in therapy of hepatitis CEmmanuel Thomas, Marc G Ghany, T Jake Liang
Journal of Hepatology|August 6, 2017
Hepatitis B cure: From discovery to regulatory approvalAnna S Lok, Fabien Zoulim, Geoffrey Dusheiko, et al.
Hepatology (Baltimore, Md.)|December 17, 2020
Liver Disease and Coronavirus Disease 2019: From Pathogenesis to Clinical CareAntonio Saviano, Florian Wrensch, Marc G Ghany, et al.
Journal of Hepatology|March 10, 2024
Reply to: "Ultrasensitive HBsAg testing predicts HBsAg seroreversion outcomes: Considerations for new and existing therapies"Marc G Ghany, Maria Buti, Pietro Lampertico, et al.
Journal of Hepatology|June 28, 2023
Guidance on treatment endpoints and study design for clinical trials aiming to achieve cure in chronic hepatitis B and D: Report from the 2022 AASLD-EASL HBV-HDV Treatment Endpoints ConferenceMarc G Ghany, Maria Buti, Pietro Lampertico, et al.
Pageof 19